Therefore, in the subgroup comparisons of this meta-analysis, the diagnostic value of combined testing of urinary cell cycle arrest biomarkers (TIMP-2/IGFBP7) vs. single-marker testing for pediatric AKI was systematically evaluated. This evidence concerns the gene IGFBP7 and acute kidney injury.